(Q37772075)

22 August 2017

1 reference

title

Whole-brain radiation therapy in breast cancer patients with brain metastases (English)

1 reference

adaptive radiation therapy

22 August 2017

main subject

0 references

1 reference

Cyrus Chargari

1

0 references

Youlia M Kirova

8

object named as

Youlia M Kirova

1 reference

22 August 2017

François Campana

2

1 reference

22 August 2017

Jean-Yves Pierga

3

1 reference

22 August 2017

Lionel Védrine

4

1 reference

22 August 2017

Damien Ricard

5

1 reference

22 August 2017

Sylvestre Le Moulec

6

1 reference

22 August 2017

Alain Fourquet

7

1 reference

22 August 2017

language of work or name

English

0 references

publication date

13 July 2010

1 reference

Nature Reviews Clinical Oncology

22 August 2017

published in

1 reference

22 August 2017

volume

7

1 reference

22 August 2017

issue

11

1 reference

22 August 2017

page(s)

632-640

1 reference

Breast cancer metastasis to the central nervous system

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Gamma Knife radiosurgery for brain metastases from primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Analysis of outcome in patients reirradiated for brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Radiation-induced dementia in patients cured of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Radiosurgery for brain metastases: a score index for predicting prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

The influence of extent and local management on the outcome of radiotherapy for brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Stereotactic radiosurgery for four or more intracranial metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Planning and delivery of whole brain radiation therapy with simultaneous integrated boost to brain metastases and synchronous limited-field thoracic radiotherapy using helical tomotherapy: a preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Helical tomotherapy as a means of delivering scalp-sparing whole brain radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Effects of Motexafin gadolinium on tumor metabolism and radiation sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Radiation-induced cognitive dysfunction: The protective effect of ethyol in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Brain metastases from breast cancer: management approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

The management of brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

A randomized trial of surgery in the treatment of single metastases to the brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Stereotactic radiosurgery for the management of brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Stereotactic radiosurgery for multiple brain metastases from breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Factors influencing the risk of local recurrence after resection of a single brain metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Clinical practice guideline on the optimal radiotherapeutic management of brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Targeted therapy for brain metastases: improving the therapeutic ratio

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

The role of postoperative radiotherapy after resection of single brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Brain damage from anticancer treatments in adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Prognostic scores in brain metastases from breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Survival in patients with brain metastases from breast cancer: the importance of HER-2 status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Brain metastases in breast cancer: prognostic factors and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Helical tomotherapy for brain metastases: dosimetric evaluation of treatment plans and early clinical results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Reirradiation of multiple brain metastases with helical tomotherapy. A multifocal simultaneous integrated boost for eight or more lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Current management of brain metastases, with a focus on systemic options

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Irradiation induces neural precursor-cell dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

CNS complications of radiotherapy and chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Simultaneous infield boost with helical tomotherapy for patients with 1 to 3 brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Neurocognitive changes in cancer survivors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Whole brain radiotherapy with radiosensitizer for brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

A pilot study to assess the feasibility of prior scalp cooling with palliative whole brain radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Concomitant chemo-radiotherapy in clinical trials: to promote step by step rational development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.119

Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast

31 March 2020

1 reference

12 December 2020

Protection from radiation-induced alopecia with topical application of nitroxides: fractionated studies

1 reference

12 December 2020

Prevention of radiation-induced central nervous system toxicity: a role for amifostine?

1 reference

12 December 2020

Sensitization of breast cancer cells to radiation by trastuzumab

1 reference

12 December 2020

10.1038/NRCLINONC.2010.119

Identifiers

DOI

1 reference

22 August 2017

1 reference